BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.8244
+0.0412 (5.26%)
At close: Dec 12, 2025, 4:00 PM EST
0.8500
+0.0256 (3.11%)
After-hours: Dec 12, 2025, 7:29 PM EST
BioAtla Market Cap
BioAtla has a market cap or net worth of $48.47 million as of December 12, 2025. Its market cap has decreased by -39.61% in one year.
Market Cap
48.47M
Enterprise Value
46.33M
1-Year Change
-39.61%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $48.47M, a decrease of -91.61%. That is a compound annual growth rate of -39.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 46.05M | 34.23% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | 1.14B | 98.22% |
| Dec 16, 2020 | 577.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |